drugset / Trial / NCT00747032

To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

NCT00747032 ↗

Phase 3 Withdrawn Fougera Pharmaceuticals Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be applied to the affected skin, excluding the face, once daily, at approximately the same time daily.

Timeline

Start
2010-09
Primary completion
2011-02
Completion
2011-04

Outcome

Outcome not reported

Stopped (Business): “Study withdrawn due to business decisions. No subjects were treated.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator NYC 0462 Unknown — Topical

Indications